QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wei, Y. Articles by Pagliassotti, M. J. Search for Related Content PubMed PubMed Citation Articles by Wei, Y. Articles by Pagliassotti, M. J.

---

Nutrient-Gene Interactions

An Acute Increase in Fructose Concentration Increases Hepatic Glucose-6-Phosphatase mRNA via Mechanisms That Are Independent of Glycogen Synthase Kinase-3 in Rats^1,2

University of Colorado Health Sciences Center, Department of Medicine, Denver, CO 80262 and ^* Colorado State University, Department of Food Science and Human Nutrition, Fort Collins, CO 80523

³To whom correspondence should be addressed. E-mail: pagliasm{at}cahs.colostate.edu.

It appears that low amounts of fructose improve, whereas increased concentrations impair glucose tolerance and hepatic glucose metabolism. In this study, we compared directly the effects of low vs. high portal vein fructose concentrations on hepatic glucose metabolism in rats, using glucose-6-phosphatase gene expression as an endpoint. In the control group (C; n = 7), pancreatic clamps were performed using somatostatin and replacement of insulin such that basal glucose levels were maintained. In the experimental groups (n = 8/group), hyperglycemic, hyperinsulinemic pancreatic clamps were performed in which glucose (G) or glucose + fructose was infused into a jejunal vein. Fructose was infused to achieve either low (F1; <0.3 mmol/L) or high (F2; >1.0 mmol/L) portal vein concentrations. Total sugar load to the liver was equalized among the 3 experimental groups. Compared with C, liver glucose-6-phosphatase catalytic subunit mRNA was reduced by 55% in G and F1, whereas it was increased 180% in F2. F2 did not differentially affect glucose-6-phosphate translocase or phosphoenolpyruvate carboxykinase mRNA levels in liver, nor kidney glucose-6-phosphatase catalytic subunit mRNA. Livers from the F2 group were characterized by an accumulation of pentose phosphate intermediates and reduced phosphorylation of glycogen synthase kinase-3 (active form). However, in separate studies (n = 5/group), the infusion of a glycogen synthase kinase-3 inhibitor did not prevent the effects of F2 on glucose-6-phosphatase gene expression. We hypothesize that elevated fructose concentrations, similar to levels achieved after ingestion of sucrose- or fructose-enriched meals, initiate signals within the liver that elicit selective changes in hepatic gene expression.

KEY WORDS: • gene expression • liver • simple sugars

This article has been cited by other articles:

				S. H. Adams, K. L. Stanhope, R. W. Grant, B. P. Cummings, and P. J. Havel Metabolic and Endocrine Profiles in Response to Systemic Infusion of Fructose and Glucose in Rhesus Macaques Endocrinology, June 1, 2008; 149(6): 3002 - 3008. [Abstract] [Full Text] [PDF]

				S. Kirchner, E. Kwon, A. Muduli, C. Cerqueira, X.-L. Cui, and R. P. Ferraris Vanadate but Not Tungstate Prevents the Fructose-Induced Increase in GLUT5 Expression and Fructose Uptake by Neonatal Rat Intestine J. Nutr., September 1, 2006; 136(9): 2308 - 2313. [Abstract] [Full Text] [PDF]

				J. Xu, A. B. Keeton, J. L. Franklin, X. Li, D. Y. Venable, S. J. Frank, and J. L. Messina Insulin Enhances Growth Hormone Induction of the MEK/ERK Signaling Pathway J. Biol. Chem., January 13, 2006; 281(2): 982 - 992. [Abstract] [Full Text] [PDF]

				Y. Wei, D. Wang, and M. J. Pagliassotti Fructose Selectively Modulates c-jun N-Terminal Kinase Activity and Insulin Signaling in Rat Primary Hepatocytes J. Nutr., July 1, 2005; 135(7): 1642 - 1646. [Abstract] [Full Text] [PDF]

				Y. Wei and M. J. Pagliassotti Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E926 - E933. [Abstract] [Full Text] [PDF]